Task: Answer the multiple-choice question.
Question: Which compound exhibits a 11.653% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) Cc1cc(NC(=O)Cn2nc(C(=O)O)c3ccccc3c2=O)ccc1Br
b) CC(OC(=O)c1cc(=O)[nH]c2ccccc12)C(=O)Nc1ccc(Cl)cn1
Answer: a. Cc1cc(NC(=O)Cn2nc(C(=O)O)c3ccccc3c2=O)ccc1Br
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(NC(=O)Cn2nc(C(=O)O)c3ccccc3c2=O)ccc1Br
Cc1cc(NC(=O)Cn2nc(C(=O)O)c3ccccc3c2=O)ccc1Br
3-[2-(4-bromo-3-methylanilino)-2-oxoethyl]-4-oxophthalazine-1-carboxylic acid